S. Quella

发表

Depomedroxyprogesterone acetate for hot flashes.

P. Novotny, J. Sloan, C. Loprinzi, 2002, Journal of pain and symptom management.

P. Novotny, J. Sloan, C. Loprinzi, 2000, Clinical breast cancer.

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.

P. Novotny, J. Sloan, C. Loprinzi, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Definitions of hot flashes in breast cancer survivors.

J. Sloan, C. Loprinzi, D. Barton, 1998, Journal of pain and symptom management.

Megestrol acetate for the prevention of hot flashes.

J. O'fallon, J. Oesterling, C. Loprinzi, 1994, The New England journal of medicine.

Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease.

D. Wheeler, C. Herzog, P. Rossignol, 2021, Clinical journal of the American Society of Nephrology : CJASN.

PATIENT ACCRUAL TO CLINICAL TRIALS

S. Quella, 2006 .

Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes

J. Sloan, T. Pisansky, C. Loprinzi, 1998, Cancer.

Megestrol acetate for the prevention of hot flashes.

J. O'fallon, C. Loprinzi, N. E. Klatt, 1995, The New England journal of medicine.

Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.

E. Perez, T. Rummans, P. Novotny, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lack of effect of coumarin in women with lymphedema after treatment for breast cancer.

P. Novotny, J. Sloan, C. Loprinzi, 1999, The New England journal of medicine.

Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.

E. Perez, S. Antolak, P. Novotny, 1999, The Journal of urology.

A qualitative approach to defining "hot flashes" in men.

C. Loprinzi, A. M. Dose, S. Quella, 1994, Urologic nursing.

Transdermal clonidine for ameliorating post-orchiectomy hot flashes.

J. O'fallon, R. Goldberg, C. Loprinzi, 1994, The Journal of urology.

Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials.

J. O'fallon, E. Messing, P. Novotny, 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Phase III evaluation of fluoxetine for treatment of hot flashes.

E. Perez, T. Rummans, P. Novotny, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial.

P. Novotny, J. Sloan, C. Loprinzi, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review.

Y. Rosenberg, F. Zannad, R. Mehran, 2020, Journal of the American College of Cardiology.

Randomized, controlled trial of an easy-to-read informed consent statement for clinical trial participation: a study of the Eastern Cooperative Oncology Group.

T. Habermann, D. Cella, D. Fairclough, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized, C ontrolled T rial o f a n E asy-to-Read I nformed Consent S tatement f or C linical T rial P articipation: A S tudy o f the E astern C ooperative O ncology G roup

T. Habermann, D. Cella, D. Fairclough, 2003 .

Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy.

P. Novotny, J. Sloan, C. Loprinzi, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Learning and support preferences of adult patients with cancer at a comprehensive cancer center.

S. Hillman, A. M. Dose, J. H. Chelf, 2002, Oncology nursing forum.